| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥45.9B | ¥41.2B | +11.3% |
| Operating Income | ¥10.3B | ¥9.9B | +3.8% |
| Ordinary Income | ¥10.7B | ¥10.1B | +6.1% |
| Net Income | ¥7.5B | ¥7.1B | +5.1% |
| ROE | 5.4% | 5.3% | - |
FY2026 Q2 results show steady revenue growth with Revenue of 45.9B yen (YoY +11.3%), Operating Income of 10.3B yen (+3.8%), Ordinary Income of 10.7B yen (+6.1%), and Net Income of 7.5B yen (+5.1%). Operating margin stands at 22.4% while maintaining gross margin of 48.6%. Operating cash flow reached 17.5B yen, representing 2.33x net income, demonstrating strong cash generation capabilities. Free cash flow of 17.1B yen confirms robust cash conversion. However, working capital efficiency shows significant deterioration with DSO of 179 days, DIO of 405 days, and CCC of 446 days, representing material operational concerns. Contract liabilities increased to 12.9B yen from 4.4B yen YoY, indicating growing advance receipts from orders. The company maintains strong financial position with cash and deposits of 82.1B yen and equity ratio of 73.9%, while interest-bearing debt remains minimal at 10.0B yen.
Revenue increased 11.3% YoY to 45.9B yen, primarily driven by growth in core manufacturing operations. Gross profit expanded to 22.3B yen with gross margin improving to 48.6% from 51.1% prior period, reflecting favorable product mix and pricing power. Cost of sales increased 17.0% to 23.6B yen, outpacing revenue growth, which compressed gross margin percentage despite absolute gross profit growth. Operating income rose 3.8% to 10.3B yen with operating margin of 22.4% compared to 24.0% YoY, representing a 1.6pt margin contraction. SG&A expenses increased 7.6% to 12.0B yen, with SG&A ratio rising to 26.2% from 27.1%, showing improved expense leverage. R&D expenses grew 18.4% to 1.8B yen (3.9% of revenue), indicating continued investment in product development. Non-operating income contributed 0.6B yen, including FX gains of 0.2B yen, while non-operating expenses totaled 0.1B yen including interest expense of 0.1B yen, resulting in net non-operating contribution of 0.4B yen. Ordinary income of 10.7B yen exceeded operating income by 0.4B yen, consistent with typical non-operating activities. Net income of 7.5B yen after tax expense of 3.2B yen (effective tax rate 30.0%) represents net margin of 16.4%. This represents a "revenue up, profit up" pattern, though profit growth lagged revenue growth due to margin compression from higher COGS ratio and increased R&D investments.
[Profitability] ROE of 5.4% remains modest, driven by net profit margin of 16.4% and asset turnover of 0.24x, constrained by financial leverage of 1.35x reflecting conservative capital structure. Operating margin of 22.4% decreased 1.6pt from 24.0% YoY, while gross margin of 48.6% demonstrates strong pricing power despite slight compression. EBIT margin stands at 22.4%, equivalent to operating margin. [Cash Quality] Cash and deposits of 82.1B yen provide short-term debt coverage of 8.21x against short-term loans of 10.0B yen. Operating CF to net income ratio of 2.33x confirms high-quality cash-backed earnings. Working capital efficiency shows severe deterioration with DSO of 179 days (up from estimated 252 days based on receivables growth outpacing revenue), DIO of 405 days, and CCC of 446 days, representing significant operational inefficiency. [Investment Efficiency] Asset turnover of 0.24x remains low, with work-in-process representing 21.2B yen (81.2% of total inventory), indicating long production cycles. Total asset turnover reflects high cash holdings and land assets constraining efficiency. CapEx of 0.2B yen against depreciation of 0.5B yen yields CapEx to D&A ratio of 0.31x, suggesting potential underinvestment. [Financial Health] Equity ratio of 73.9% (up from 76.3%) reflects strong capitalization. Current ratio of 344.9% provides robust liquidity buffer. Debt-to-equity ratio of 0.07x and net debt to EBITDA of 0.93x confirm minimal leverage. Interest coverage ratio of 193.4x demonstrates ample debt service capacity.
Operating CF of 17.5B yen represents 2.33x net income, confirming strong cash generation quality with operating CF subtotal before working capital changes of 21.5B yen. Change in contract liabilities contributed positive 8.5B yen, reflecting increased customer advance payments. Accounts receivable declined 5.7B yen, improving cash collection, while inventory increased 2.1B yen despite strong sales growth, indicating production build-up. Accounts payable increased 0.6B yen, providing modest supplier financing. Income taxes paid of 4.0B yen represented cash outflow. Investing CF of -0.4B yen was minimal, comprising CapEx of 0.2B yen and other investments. The low CapEx level relative to depreciation of 0.5B yen yields CapEx to D&A ratio of 0.31x, raising concerns about future capacity maintenance. Financing CF of -5.0B yen primarily reflected dividend payments of 4.8B yen and long-term loan repayment of 0.2B yen. FCF of 17.1B yen demonstrates robust cash generation after minimal capital investment needs. Cash and deposits increased to 82.1B yen from 69.8B yen YoY, representing significant liquidity accumulation. The company's cash position covers short-term debt 8.2x, indicating strong financial flexibility despite elevated working capital absorption.
Ordinary income of 10.7B yen versus operating income of 10.3B yen shows non-operating net contribution of approximately 0.4B yen, representing 0.9% of revenue. This comprises primarily FX gains of 0.2B yen and minimal interest income of 0.02B yen, offset by interest expense of 0.1B yen and commission fees of 0.1B yen. Non-operating items remain modest relative to operating performance, indicating core earnings quality is not distorted by financial activities. Interest and dividend income received of 0.1B yen during the period reflects minimal investment income despite large cash holdings. Operating CF of 17.5B yen significantly exceeds net income of 7.5B yen, yielding cash conversion ratio of 2.33x, indicating superior earnings quality with strong accruals reversal. The positive spread is primarily driven by contract liability increase of 8.5B yen and favorable receivables collection. Accrual ratio of -5.3% (negative indicates cash exceeds accruals) confirms operating income is well-backed by cash flows. No extraordinary items such as impairment losses, asset sales, or restructuring charges were reported, supporting sustainability of reported earnings. Tax expense of 3.2B yen on profit before tax of 10.7B yen yields effective tax rate of 30.0%, consistent with statutory rates and indicating normal tax profile.
First half results show revenue progress rate of 45.0% (45.9B yen vs. full-year guidance of 102.0B yen) and operating income progress rate of 41.8% (10.3B yen vs. 24.6B yen), both slightly below the standard 50% benchmark for Q2. Ordinary income progress at 43.9% (10.7B yen vs. 24.4B yen) and net income progress at 43.6% (7.5B yen vs. 17.2B yen) also trail standard pace. The progress shortfall of 4-8 percentage points suggests second half weighting or potential execution challenges, though contract liabilities of 12.9B yen (representing 12.6% of full-year revenue guidance) provide visibility into future revenue conversion. Backlog to revenue ratio of 0.28x (contract liabilities to annualized H1 revenue) indicates approximately 3.4 months of forward revenue coverage. Full-year guidance anticipates revenue growth of 9.2%, operating income growth of 5.0%, ordinary income growth of 2.8%, and net income growth of 1.4%, reflecting expected second-half margin compression from first-half levels. No guidance revisions were made this quarter. The deceleration in profit growth guidance relative to revenue suggests anticipated cost pressures or investments in second half.
Q2 dividend was zero yen as the company typically distributes dividends annually. Full-year dividend forecast of 60.00 yen per share represents projected payout ratio of approximately 28.0% based on forecasted EPS of 214.38 yen, indicating conservative dividend policy with substantial retained earnings for reinvestment. Based on H1 net income of 7.5B yen annualized and forecast dividend payout, the company maintains dividend coverage ratio of approximately 3.6x, providing comfortable margin for dividend sustainability. Share repurchases during the period were minimal at 0.0B yen, indicating limited capital return through buybacks. Total return ratio based on forecast remains primarily dividend-driven at approximately 28%. The company's cash position of 82.1B yen and operating CF of 17.5B yen provide ample resources to support both dividends and potential increased returns. With FCF of 17.1B yen exceeding projected annual dividends substantially, dividend policy appears sustainable, though elevated working capital absorption could pressure future cash generation if unaddressed.
Working capital management deterioration: DSO of 179 days and DIO of 405 days creating CCC of 446 days represents significant cash conversion risk and potential collection or obsolescence exposure, requiring urgent operational improvement to prevent cash flow volatility and potential write-downs.
Manufacturing process concentration: Work-in-process inventory of 21.2B yen representing 81.2% of total inventory indicates long production lead times and potential bottleneck risk in production cycles, exposing the company to demand shifts and execution delays.
Capital investment adequacy: CapEx to depreciation ratio of 0.31x signals potential underinvestment in capacity maintenance and technology refresh, risking future competitive position and production efficiency if sustained over multiple periods.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability metrics significantly exceed industry norms, with ROE of 5.4% above the industry median of 4.4% (ranking in upper quartile), operating margin of 22.4% substantially outperforming median of 8.8% (top performer), and net profit margin of 16.4% well above median of 5.4% (top quartile), demonstrating superior pricing power and operational efficiency. Financial health indicators show equity ratio of 73.9% substantially above industry median of 48.6%, reflecting highly conservative capital structure, while current ratio of 344.9% exceeds median of 2.74x, indicating exceptional liquidity position. Efficiency metrics reveal contrasts: asset turnover of 0.24x significantly lags industry median of 0.36x, reflecting high cash and fixed asset holdings constraining capital efficiency. Working capital metrics show severe underperformance with receivables turnover of 179 days far exceeding median of 105 days, inventory turnover of 405 days substantially worse than median of 261 days, and operating working capital cycle of 446 days versus median of 170 days, representing bottom-tier working capital efficiency. Growth profile shows revenue growth of 11.3% aligned with industry median of 11.7%, positioning the company as steady performer, while EPS growth of 5.1% underperforms median of 45.0% due to margin compression. Cash generation metrics demonstrate cash conversion ratio of 2.33x outperforming median of 0.91x, confirming superior cash-backed earnings quality despite operational inefficiencies.
(※ Industry: Manufacturing (N=7 companies), Comparison: 2025-Q2 period, Source: Proprietary analysis)
Superior profitability with structural challenges: Operating margin of 22.4% and net margin of 16.4% position the company in top tier of manufacturing sector, demonstrating sustainable competitive advantages through pricing power and operational excellence, though margin contracted 1.6pt YoY, warranting monitoring of cost pressures and pricing sustainability in face of 17.0% COGS growth outpacing 11.3% revenue growth.
Working capital efficiency requires urgent remediation: DSO of 179 days (70% above industry median), DIO of 405 days (155% above median), and CCC of 446 days (163% above median) represent severe operational inefficiency, absorbing substantial cash and creating collection and obsolescence risks that could materially impair future cash generation and profitability if unaddressed, despite current strong operating CF of 17.5B yen benefiting from one-time contract liability increase of 8.5B yen.
Conservative financial positioning with capital allocation considerations: Equity ratio of 73.9%, cash holdings of 82.1B yen (43.7% of assets), and minimal leverage (D/E 0.07x) provide substantial financial flexibility and downside protection, while ROE of 5.4% and asset turnover of 0.24x indicate significant room for efficiency improvement through optimized capital deployment, particularly given CapEx to D&A ratio of 0.31x suggesting potential underinvestment in growth and productivity enhancement, requiring strategic clarification on capital allocation priorities between balance sheet optimization, growth investments, and enhanced shareholder returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.